# JYLAMVO

NDC: 81927-204
Generic name: Methotrexate
Labeler / Manufacturer: SHORLA ONCOLOGY INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20231215

FDA application: NDA212479

## Active ingredients

- METHOTREXATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81927-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81927-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96e931f5-51ae-4bdf-a441-bb0dd26d4c0e